Health
Moderna has started testing its COVID-19 vaccine in babies and young children – SBS
Moderna has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine in children aged six months to less than 12 years.
US manufacturer Moderna on Tuesday said it has started COVID-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enrol about 6,750 participants.
“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” said CEO Stephane Bancel in a statement.
“This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population.”
US health authorities…
-
General22 hours agoDonald Trump and Anthony Albanese sign critical minerals deal
-
Business21 hours agoThe ASX ETF I'd suggest buying to any family member
-
Noosa News22 hours agoAustralians turning to ChatGPT and other AI for financial advice warned to tread with caution
-
Noosa News13 hours agoForensic teams, dogs descend on scene of alleged murder